<DOC>
	<DOCNO>NCT00939042</DOCNO>
	<brief_summary>Study assess efficacy intramyocardial bone marrow derive mononuclear cell therapy concern leave ventricular ejection fraction measure echocardiography .</brief_summary>
	<brief_title>Alster Stem Cells - Intramyocardial Stem Therapy</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>LVDF &lt; 45 % timely ( max . 6 hour onset symptomps ) successful PCI conventional therapy accord ESC guideline heart failure BMI &gt; 20 &lt; 35 PCI elder 21 day relevant valvular disease history stroke/multivessel disease/thromboembolic event etc . DM Type I pregancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>